The tortoise (Eli Lilly) has caught the hare (Novo Nordisk), according to a report from BMO Capital Markets, which cites the superior commercial and clinical portfolios of the Indianapolis company ...

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral ...

Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

BMO Capital downgraded Novo Nordisk (NVO) to Market Perform from Outperform with a price target of $64, down from $105. The company’s obesity ...

The U.S. Food and Drug Administration is warning people of counterfeit versions of a popular weight loss drug are circulating ...

AC drilling commenced at the Balla Balla Gold Project 1 in the Pilbara, Western Australia. The ~6,000 m program is testing priority target zones ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...

The wide-ranging executive order signed by Trump aims to reduce healthcare costs. It comes one day after the Trump ...

The Times Opinion columnist discusses what he thinks Trump — and American policymakers — misunderstand about China in the ...